0001562180-23-005500.txt : 20230626
0001562180-23-005500.hdr.sgml : 20230626
20230626162845
ACCESSION NUMBER: 0001562180-23-005500
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230622
FILED AS OF DATE: 20230626
DATE AS OF CHANGE: 20230626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carruthers R Michael
CENTRAL INDEX KEY: 0001644467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 231042712
MAIL ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-262-7002
MAIL ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0407
4
2023-06-22
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001644467
Carruthers R Michael
C/O EDGEWISE THERAPEUTICS, INC.
3145 COLORADO AVE
BOULDER
CO
80303
false
true
false
false
Chief Financial Officer
false
Common Stock
2023-06-22
4
M
false
10000.00
0.71
A
29024.00
D
Stock Options (Right to buy)
0.71
2023-06-22
4
M
false
10000.00
0.00
D
2030-09-01
Common Stock
10000.00
197122.00
D
Includes 2,898 shares purchased on May 15, 2023 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.
/s/ John R. Moore Attorney-in-Fact for R. Michael Carruthers
2023-06-26